INS and Insulin resistance: Treatment of the diabetic rats with linagliptin led to a significant increase in both insulin and C-peptide secretion when compared with the diabetic animals which suffer from insulin resistance as well as damage to β-cells in the islets of Langerhans due to the effect of NA/STZ injection.